At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $246.39M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 3.12: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.98%Above 5Y avg (2.42%)
Annual Rate
JPY 40.00Paid semi-annual
Payout Ratio
37.9%Sustainable
Next Ex-Dividend
Nov 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
39.34BJPY246.39M · vs all stocks (USD)
Trailing P/E
12.68xRevenue (TTM)
49.53BJPY310.21M · vs all stocks (USD)
Profit Margin
6.39%52-Week Change
7.46%vs all stocks
Forward Annual Dividend Yield
2.98%vs all stocks
Market Capitalization
39.34BJPY246.39M · vs all stocks (USD)
Enterprise Value
45.36BJPY284.09M · vs all stocks (USD)
Trailing P/E
12.68xForward P/E
6.28xPEG Ratio
-0.2379xPrice to Sales (TTM)
0.7736xPrice to Book (MRQ)
0.7352xEnterprise to Revenue
0.9160xEnterprise to EBITDA
5.85xProfit Margin
6.39%Operating Margin
6.00%Return on Assets (TTM)
2.78%Return on Equity (TTM)
6.07%Revenue (TTM)
49.53BJPY310.21M · vs all stocks (USD)
Revenue per Share (TTM)
1.71KJPYUpdated Oct 21, 2026Quarterly Revenue Growth
-8.60%Gross Profit (TTM)
9.53BJPY59.70M · vs all stocks (USD)
EBITDA (TTM)
8.25BJPY51.67M · vs all stocks (USD)
Net Income (TTM)
3.16BJPY19.82M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.60%Operating Cash Flow (TTM)
9.38BJPY58.73M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.16BJPY19.80M · vs all stocks (USD)
Forward Annual Dividend Rate
40.00JPYUpdated Oct 21, 2026Forward Annual Dividend Yield
2.98%vs all stocks
Trailing Annual Dividend Rate
40.00JPYUpdated Oct 21, 2026Trailing Annual Dividend Yield
2.98%vs all stocks
5-Year Average Dividend Yield
2.42%vs all stocks
Payout Ratio
37.90%Minority Interest (Equity)
46.00MJPYFY2026 · May 31, 2026Revenue
50.65BJPYFY2026 · May 31, 2026Cost of Goods Sold
40.75BJPYFY2026 · May 31, 2026Gross Profit
9.90BJPYFY2026 · May 31, 2026Operating Income
3.64BJPY22.78M · vs all stocks (USD)
Pre-tax Income
4.07BJPYFY2026 · May 31, 2026Income Tax Expense
928.00MJPYFY2026 · May 31, 2026Net Income
3.14BJPYFY2026 · May 31, 2026EBIT
4.20BJPYFY2026 · May 31, 2026EBITDA (Income Statement)
8.25BJPYFY2026 · May 31, 2026Non-operating Interest Income
1.00MJPYFY2026 · May 31, 2026Non-operating Interest Expense
130.00MJPYFY2026 · May 31, 2026EPS (Basic)
107.49JPYFY2026 · May 31, 2026EPS (Diluted)
107.49JPYFY2026 · May 31, 2026Basic Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Diluted Shares Outstanding
29.41MSharesFY2026 · May 31, 2026Minority Interests (P&L)
25.00MJPYFY2026 · May 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · May 31, 2026Operating Cash Flow
9.38BJPYFY2026 · May 31, 2026Cash & Cash Equivalents (End of Period)
954.00MJPYFY2026 · May 31, 2026Starting Profit (CF Statement)
4.07BJPYFY2026 · May 31, 2026Other Non-cash Items
-39.00MJPYFY2026 · May 31, 2026Change in Accounts Receivable (CF)
1.35BJPYFY2026 · May 31, 2026Change in Other Assets/Liabilities
2.02BJPYFY2026 · May 31, 2026Net Intangibles (CF)
-1.37BJPYFY2026 · May 31, 2026Net Acquisitions
0.00JPYFY2026 · May 31, 2026Purchase of Investments
0.00JPYFY2026 · May 31, 2026Sale of Investments
454.00MJPYFY2026 · May 31, 2026Other Investing Activity
375.00MJPYFY2026 · May 31, 2026Net Investing Cash Flow
829.00MJPYFY2026 · May 31, 2026Long-term Debt Issuance
0.00JPYFY2026 · May 31, 2026Long-term Debt Payments
-3.10BJPYFY2026 · May 31, 2026Common Stock Repurchase
-1.63BJPYFY2026 · May 31, 2026Common Dividends Paid
-1.12BJPYFY2026 · May 31, 2026Other Financing Charges
-1.00MJPYFY2026 · May 31, 2026Net Financing Cash Flow
-5.85BJPYFY2026 · May 31, 2026Shares Outstanding
28.74MSharesUpdated Oct 21, 2026Float Shares
25.10MSharesUpdated Oct 21, 2026% Held by Insiders
15.44%vs all stocks
% Held by Institutions
33.52%vs all stocks
Total Cash (MRQ)
1.69BJPY10.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
59.36JPYUpdated Oct 21, 2026Total Debt (MRQ)
8.45BJPY52.89M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1609xCurrent Ratio (MRQ)
2.64xBook Value per Share (MRQ)
1.84KJPYUpdated Oct 21, 2026Total Assets
73.29BJPY458.99M · vs all stocks (USD)
Total Current Assets
36.63BJPYFY2026 · May 31, 2026Total Liabilities
20.35BJPYFY2026 · May 31, 2026Total Non-current Assets
36.66BJPYFY2026 · May 31, 2026Total Non-current Liabilities
6.36BJPYFY2026 · May 31, 2026Total Current Liabilities
14.00BJPYFY2026 · May 31, 2026Cash & Cash Equivalents
954.00MJPYFY2026 · May 31, 2026Accounts Receivable
12.79BJPYFY2026 · May 31, 2026Inventory
16.44BJPYFY2026 · May 31, 2026Accounts Payable
5.23BJPYFY2026 · May 31, 2026Short-term Debt
3.32BJPYFY2026 · May 31, 2026Other Current Liabilities
2.41BJPYFY2026 · May 31, 2026Long-term Debt
5.97BJPYFY2026 · May 31, 2026Other Non-current Liabilities
230.00MJPYFY2026 · May 31, 2026Common Stock (Book)
7.19BJPYFY2026 · May 31, 2026Retained Earnings
36.97BJPYFY2026 · May 31, 2026Total Shareholders' Equity
52.94BJPY331.53M · vs all stocks (USD)
Treasury Stock
128.00MJPYFY2026 · May 31, 202652-Week Low
1.12KJPYUpdated Oct 21, 202652-Week High
1.52KJPYUpdated Oct 21, 202652-Week Change
7.46%vs all stocks
50-Day MA
1.32KJPYUpdated Oct 21, 2026200-Day MA
1.32KJPYUpdated Oct 21, 2026Avg 10-Day Volume
80.37KSharesUpdated Oct 21, 2026Avg 30-Day Volume
77.36KSharesUpdated Oct 21, 2026Diluted EPS (TTM)
106.94JPYUpdated Oct 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.04Revenue Growth YoY: -0.09
Financial Health
Altman Z-Score 3.12: safe zoneNotable
Altman Z-Score: 3.12
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $246.39M, lower than 95% of all stocks globallySignificant
Market cap (USD): 246,385,709.693Global P5: 273,689,256.68
Levered free cash flow is $19.8M, above the global median of $18.58MNotable
Levered free cash flow (USD): 19,796,394.7Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Heartseed Inc.
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Lyell Immunopharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Jiangsu GDK Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Larimar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sisram Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Standard Biotools Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tanvex Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Nucien Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk